Literature DB >> 12395555

Immediate and delayed memory tasks: a computerized behavioral measure of memory, attention, and impulsivity.

Donald M Dougherty1, Dawn M Marsh, Charles W Mathias.   

Abstract

The Immediate and Delayed Memory Task (IMT/DMT), a variant of the Continuous Performance Test (CPT), is a new software package designed to be a flexible research tool for the study of attention, memory, and impulsivity. This package allows researchers to determine the design to be used during a testing session and to manipulate many of the parameters. It features two components: the IMT and the DMT, both of which present sequential 2- to 7-digit stimuli with variable presentation rates and intertrial intervals. Subjects respond to identically matched stimuli presented consecutively, spanning a brief period of time (IMT), or to stimuli spanning a greater period of time (during which intervening stimuli to be ignored appear; DMT). Task complexity can be adjusted to suit applications for both children and adults. Preliminary studies have demonstrated that these laboratory tasks are sensitive to group differences, produce stable baselines of performance, and are sensitive to drug-induced performance decrements.

Entities:  

Mesh:

Year:  2002        PMID: 12395555     DOI: 10.3758/bf03195467

Source DB:  PubMed          Journal:  Behav Res Methods Instrum Comput        ISSN: 0743-3808


  59 in total

1.  Distinctions in Behavioral Impulsivity: Implications for Substance Abuse Research.

Authors:  Donald M Dougherty; Charles W Mathias; Dawn M Marsh-Richard; R Michael Furr; Sylvain O Nouvion; Michael A Dawes
Journal:  Addict Disord Their Treat       Date:  2009-06-01

2.  Individual Differences in Impulsive Action Reflect Variation in the Cortical Serotonin 5-HT2A Receptor System.

Authors:  Latham H L Fink; Noelle C Anastasio; Robert G Fox; Kenner C Rice; F Gerard Moeller; Kathryn A Cunningham
Journal:  Neuropsychopharmacology       Date:  2015-02-10       Impact factor: 7.853

3.  Relationship between impulsivity and decision making in cocaine dependence.

Authors:  Kimberly L Kjome; Scott D Lane; Joy M Schmitz; Charles Green; Liangsuo Ma; Irshad Prasla; Alan C Swann; F Gerard Moeller
Journal:  Psychiatry Res       Date:  2010-05-15       Impact factor: 3.222

4.  Allopregnanolone association with psychophysiological and cognitive functions during acute smoking abstinence in premenopausal women.

Authors:  Alicia M Allen; Mustafa al'Absi; Harry Lando; Sharon S Allen
Journal:  Exp Clin Psychopharmacol       Date:  2015-02       Impact factor: 3.157

5.  A test of alcohol dose effects on multiple behavioral measures of impulsivity.

Authors:  Donald M Dougherty; Dawn M Marsh-Richard; Erin S Hatzis; Sylvain O Nouvion; Charles W Mathias
Journal:  Drug Alcohol Depend       Date:  2008-04-02       Impact factor: 4.492

6.  Feasibility and Findings from a Novel Working Memory fMRI Paradigm in Multiple Sclerosis.

Authors:  F Nelson; J Steinberg
Journal:  J Neurol Disord Stroke       Date:  2013-09

Review 7.  Are there volumetric brain differences associated with the use of cocaine and amphetamine-type stimulants?

Authors:  Scott Mackey; Martin Paulus
Journal:  Neurosci Biobehav Rev       Date:  2012-12-17       Impact factor: 8.989

8.  Pubertal Maturation Compression and Behavioral Impulsivity among Boys at Increased Risk for Substance Use.

Authors:  Charles W Mathias; Nora E Charles; Yuanyuan Liang; Ashley Acheson; Sarah L Lake; Stacy R Ryan; Rene L Olvera; Donald M Dougherty
Journal:  Addict Disord Their Treat       Date:  2016-06

9.  Delay discounting differentiates pre-adolescents at high and low risk for substance use disorders based on family history.

Authors:  Donald M Dougherty; Nora E Charles; Charles W Mathias; Stacy R Ryan; Rene L Olvera; Yuanyuan Liang; Ashley Acheson
Journal:  Drug Alcohol Depend       Date:  2014-07-23       Impact factor: 4.492

10.  Alcohol increases impulsivity and abuse liability in heavy drinking women.

Authors:  Stephanie Collins Reed; Frances R Levin; Suzette M Evans
Journal:  Exp Clin Psychopharmacol       Date:  2012-10-15       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.